LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation on behalf of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On August 17, 2020, Applied Therapeutics revealed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Company’s ACTION-Kids study, citing the need for additional technical information to ensure that each study participant has access to the drug’s benefits. The ACTION-Kids study is evaluating the Company’s AT-007 drug for the treatment of galactosemia.
On this news, the Company’s shares fell $3.53 per share, or 12.07%, to close at $25.71 per share on August 17, 2020.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Applied Therapeutics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
